Aprogen Medicines Revenue

In the year 2024, Aprogen Medicines had annual revenue of 150.11B KRW, down -0.31%. Aprogen Medicines had revenue of 39.65B in the quarter ending December 31, 2024, with 6.05% growth.

Revenue

150.11B

Revenue Growth

-0.31%

P/S Ratio

1.44

Revenue / Employee

612.71M

Employees

245

Market Cap

216.26B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	150.11B	-464.40M	-0.31%
Dec 31, 2023	150.58B	72.23B	92.19%
Dec 31, 2022	78.35B	52.05B	197.95%
Dec 31, 2021	26.30B	-100.85B	-79.32%
Dec 31, 2020	127.14B	48.89B	62.48%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2012	Pro	Pro	Pro
Dec 31, 2011	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
LG Energy Solution	25.62T
Hanwha Aerospace	11.24T
HD Hyundai Heavy Industries	14.49T
Hanwha Ocean	10.78T
Samsung C&T	42.10T
HMM Co.,Ltd	11.70T
HD Korea Shipbuilding & Offshore Engineering	25.54T
Doosan Enerbility	16.23T

Revenue Rankings